Menu
GeneBe

2-42767878-G-A

Variant summary

Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BS1_Supporting

The NM_012205.3(HAAO):c.681C>T(p.Asp227=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00228 in 1,614,010 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0017 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0023 ( 7 hom. )

Consequence

HAAO
NM_012205.3 synonymous

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.514
Variant links:
Genes affected
HAAO (HGNC:4796): (3-hydroxyanthranilate 3,4-dioxygenase) 3-Hydroxyanthranilate 3,4-dioxygenase is a monomeric cytosolic protein belonging to the family of intramolecular dioxygenases containing nonheme ferrous iron. It is widely distributed in peripheral organs, such as liver and kidney, and is also present in low amounts in the central nervous system. HAAO catalyzes the synthesis of quinolinic acid (QUIN) from 3-hydroxyanthranilic acid. QUIN is an excitotoxin whose toxicity is mediated by its ability to activate glutamate N-methyl-D-aspartate receptors. Increased cerebral levels of QUIN may participate in the pathogenesis of neurologic and inflammatory disorders. HAAO has been suggested to play a role in disorders associated with altered tissue levels of QUIN. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -1 ACMG points.

BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00165 (252/152374) while in subpopulation NFE AF= 0.00288 (196/68032). AF 95% confidence interval is 0.00255. There are 0 homozygotes in gnomad4. There are 96 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
HAAONM_012205.3 linkuse as main transcriptc.681C>T p.Asp227= synonymous_variant 8/10 ENST00000294973.11
HAAOXM_011532729.4 linkuse as main transcriptc.591C>T p.Asp197= synonymous_variant 7/9
HAAOXM_011532730.4 linkuse as main transcriptc.579C>T p.Asp193= synonymous_variant 9/11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
HAAOENST00000294973.11 linkuse as main transcriptc.681C>T p.Asp227= synonymous_variant 8/101 NM_012205.3 P1P46952-1
HAAOENST00000402698.6 linkuse as main transcriptn.1025C>T non_coding_transcript_exon_variant 7/95
HAAOENST00000404451.7 linkuse as main transcriptn.440C>T non_coding_transcript_exon_variant 6/63
HAAOENST00000406007.6 linkuse as main transcriptn.232C>T non_coding_transcript_exon_variant 2/42

Frequencies

GnomAD3 genomes
AF:
0.00166
AC:
252
AN:
152256
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000699
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000785
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000620
Gnomad FIN
AF:
0.00104
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00288
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00154
AC:
386
AN:
251360
Hom.:
0
AF XY:
0.00149
AC XY:
202
AN XY:
135850
show subpopulations
Gnomad AFR exome
AF:
0.000677
Gnomad AMR exome
AF:
0.000492
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000109
Gnomad SAS exome
AF:
0.000229
Gnomad FIN exome
AF:
0.000647
Gnomad NFE exome
AF:
0.00289
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.00234
AC:
3423
AN:
1461636
Hom.:
7
Cov.:
31
AF XY:
0.00233
AC XY:
1692
AN XY:
727130
show subpopulations
Gnomad4 AFR exome
AF:
0.000538
Gnomad4 AMR exome
AF:
0.000514
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000290
Gnomad4 FIN exome
AF:
0.000618
Gnomad4 NFE exome
AF:
0.00291
Gnomad4 OTH exome
AF:
0.00144
GnomAD4 genome
AF:
0.00165
AC:
252
AN:
152374
Hom.:
0
Cov.:
33
AF XY:
0.00129
AC XY:
96
AN XY:
74518
show subpopulations
Gnomad4 AFR
AF:
0.000697
Gnomad4 AMR
AF:
0.000784
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.000621
Gnomad4 FIN
AF:
0.00104
Gnomad4 NFE
AF:
0.00288
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.00204
Hom.:
0
Bravo
AF:
0.00157
EpiCase
AF:
0.00202
EpiControl
AF:
0.00213

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGeneDxMar 08, 2022Has not been previously published as pathogenic or benign to our knowledge; In-silico analysis is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
Cadd
Benign
5.1
Dann
Benign
0.81
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.24
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.24
Position offset: -18

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs150537416; hg19: chr2-42995018; COSMIC: COSV54311575; COSMIC: COSV54311575; API